NCT04241458View on ClinicalTrials.gov

A Study to Test How Well Healthy Men and Women Tolerate Different Doses of BI 706321

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 30, 2020

Primary Completion Date

November 24, 2020

Study Completion Date

November 24, 2020

Conditions
Healthy
Interventions
DRUG

BI 703621

BI 703621

DRUG

Placebo

Placebo

DRUG

Midazolam

Midazolam

Trial Locations (1)

2650

SGS Life Science Services - Clinical Research, Edegem

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04241458 - A Study to Test How Well Healthy Men and Women Tolerate Different Doses of BI 706321 | Biotech Hunter | Biotech Hunter